Supplementary Data 2 from A Phase Ib/II Trial of the First-in-Class Anti-CXCR4 Antibody Ulocuplumab in Combination with Lenalidomide or Bortezomib Plus Dexamethasone in Relapsed Multiple MyelomaIrene M. Ghobrial, Chia-Jen Liu,Robert A. Redd,Raymond P. Perez,Rachid Baz,Oksana Zavidij,Romanos Sklavenitis-Pistofidis,Paul G. Richardson,Kenneth C. Anderson,Jacob Laubach,Patrick Henrick,Alexandra Savell,Kaitlen Reyes,Kalvis Hornburg,Stacey Chuma,Peter Sabbatini,Michael D. Robbins, Pamela S. Beckercrossref（2023）引用 0|浏览2暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
